Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Mandelli

Showing results (411-420 of 573) with videos related to

Pageof 58
Sort By:
Haematologica|July 1, 1994
Prognostic value of bone marrow histology in chronic lymphocytic leukemia. A study of 335 untreated cases from a single institutionF R Mauro, G De Rossi, V L Burgio, et al.
European Journal of Haematology|March 1, 1991
Chronic myeloid leukaemia lymphoid blast crisis. Relevance of molecular analysis at the bcr and immunoglobulin heavy chain gene level in monitoring response to therapy and residual diseaseF Lo Coco, D Diverio, M Frontani, et al.
British Journal of Haematology|October 1, 1991
Is interferon alpha in cutaneous T-cell lymphoma a treatment of choice?G Papa, S Tura, F Mandelli, et al.
Leukemia|January 1, 1991
Nine years' experience with ABMT in 128 patients with Hodgkin's disease: an Italian study group reportA m Carella, P Carlier, A Congiu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1989
Response to pentostatin in hairy-cell leukemia refractory to interferon-alpha. The European Organization for Research and Treatment of Cancer Leukemia Cooperative GroupA D Ho, J Thaler, F Mandelli, et al.
Haematologica|February 1, 1980
Treatment of non Hodgkin's lymphoma with "PROVECIP" (procarbazine, vinblastine, cyclophosphamide and prednisone)F Mandelli, C Biagini, C D Baroni, et al.
Bone Marrow Transplantation|October 1, 1990
Therapy-induced Ph1 suppression in chronic myeloid leukemia: molecular and cytogenetic studies in patients treated with alpha-2b IFN, high-dose chemotherapy and autologous stem cell infusionF Lo Coco, F Mandelli, D Diverio, et al.
Haematologica|November 1, 1987
Human acute myelogenous and lymphoid leukemias: pattern of expression of cellular oncogenesN M Sposi, F Mavilio, M Petrini, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1983
Transfused and pharmacological iron: relationship of overload to HLA antigensM Taccone-Gallucci, G D Di Nucci, C Meloni, et al.
Leukemia|April 1, 1995
In vitro purging with BCR-ABL antisense oligodeoxynucleotides does not prevent haematologic reconstitution after autologous bone marrow transplantationP de Fabritis, S Amadori, M C Petti, et al.
Pageof 58

Showing results (411-420 of 573) with videos related to

Sort By:
Pageof 58
Haematologica|July 1, 1994
Prognostic value of bone marrow histology in chronic lymphocytic leukemia. A study of 335 untreated cases from a single institutionF R Mauro, G De Rossi, V L Burgio, et al.
European Journal of Haematology|March 1, 1991
Chronic myeloid leukaemia lymphoid blast crisis. Relevance of molecular analysis at the bcr and immunoglobulin heavy chain gene level in monitoring response to therapy and residual diseaseF Lo Coco, D Diverio, M Frontani, et al.
British Journal of Haematology|October 1, 1991
Is interferon alpha in cutaneous T-cell lymphoma a treatment of choice?G Papa, S Tura, F Mandelli, et al.
Leukemia|January 1, 1991
Nine years' experience with ABMT in 128 patients with Hodgkin's disease: an Italian study group reportA m Carella, P Carlier, A Congiu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1989
Response to pentostatin in hairy-cell leukemia refractory to interferon-alpha. The European Organization for Research and Treatment of Cancer Leukemia Cooperative GroupA D Ho, J Thaler, F Mandelli, et al.
Haematologica|February 1, 1980
Treatment of non Hodgkin's lymphoma with "PROVECIP" (procarbazine, vinblastine, cyclophosphamide and prednisone)F Mandelli, C Biagini, C D Baroni, et al.
Bone Marrow Transplantation|October 1, 1990
Therapy-induced Ph1 suppression in chronic myeloid leukemia: molecular and cytogenetic studies in patients treated with alpha-2b IFN, high-dose chemotherapy and autologous stem cell infusionF Lo Coco, F Mandelli, D Diverio, et al.
Haematologica|November 1, 1987
Human acute myelogenous and lymphoid leukemias: pattern of expression of cellular oncogenesN M Sposi, F Mavilio, M Petrini, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1983
Transfused and pharmacological iron: relationship of overload to HLA antigensM Taccone-Gallucci, G D Di Nucci, C Meloni, et al.
Leukemia|April 1, 1995
In vitro purging with BCR-ABL antisense oligodeoxynucleotides does not prevent haematologic reconstitution after autologous bone marrow transplantationP de Fabritis, S Amadori, M C Petti, et al.
Pageof 58